2004

1. Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

   Critical Care Medicine, Vol. 32, Núm. 2, pp. 332-341